Tofranil and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tofranil (imipramine hydrochloride) and Restoril (temazepam). Common drug interactions include diabetic ketoacidosis among females and overdose among males.

The phase IV clinical study analyzes what interactions people have when they take Tofranil and Restoril. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Tofranil?

Tofranil has active ingredients of imipramine hydrochloride. It is often used in depression. eHealthMe is studying from 2,012 Tofranil users. Check the latest studies of Tofranil.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 26, 2026

12 people who take Tofranil and Restoril together, and have interactions are studied.

Tofranil and Restoril drug interactions.

What are the common drug interactions of Tofranil and Restoril, by gender? *:

female:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Urinary tract infection
  3. Suicide attempt
  4. Abdominal pain
  5. Accident
  6. Drug ineffective
  7. Hallucination (an experience involving the perception of something not present)
  8. Intestinal resection
  9. Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal)
  10. Ovarian cyst (fluid filled sac of the ovary)

male:

  1. Overdose
  2. Aggression
  3. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  4. Completed suicide (act of taking one's own life)
  5. Hallucination (an experience involving the perception of something not present)
  6. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  7. Chest pain
  8. Confusion
  9. Death
  10. Hospitalisation

What are the common drug interactions of Tofranil and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal)
  3. Ovarian cyst (fluid filled sac of the ovary)

30-39:

  1. Suicide attempt
  2. Suicidal ideation

40-49:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Urinary tract infection
  3. Chest pain
  4. Death
  5. Hospitalisation
  6. Overdose
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

50-59:

  1. Hallucination (an experience involving the perception of something not present)
  2. Aggression
  3. Completed suicide (act of taking one's own life)
  4. Overdose
  5. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  6. Accident
  7. Drug ineffective
  8. Restlessness (not able to rest)

60+:

  1. Confusion
  2. Intestinal resection

What are the existing conditions these people have? *

  1. Stress And Anxiety: 2 people, 16.67%
  2. Sleep Disorder: 2 people, 16.67%
  3. Nausea (feeling of having an urge to vomit): 2 people, 16.67%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 16.67%
  5. Flatulence (flatus expelled through the anus): 2 people, 16.67%
  6. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 1 person, 8.33%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
  8. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tofranil and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tofranil and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tofranil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tofranil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on imipramine hydrochloride and temazepam (the active ingredients of Tofranil and Restoril, respectively), and Tofranil and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: